Loading ...
Sorry, an error occurred while loading the content.

The Fifth Chancellor Tien Forum-Dr. Frank Kung (Tsing Hua Alumni)

Expand Messages
  • echarliechao
    Monte Jade 2006 The Fifth Chancellor Tien Forum Speaker: Dr. Frank Kung (孔繁建博士) Founder, Managing Member, Vivo Ventures Perfecting Life—witnessing
    Message 1 of 1 , Oct 3, 2006
      Monte Jade 2006

      The Fifth Chancellor Tien Forum

      Speaker: Dr. Frank Kung (孔繁建博士)

      Founder, Managing Member, Vivo Ventures

      "Perfecting Life—witnessing the 30 year Growth of Life Sciences Industry"

      Time: October 12 (Thursday), 2006, 6:30-8:00pm

      Place: ITRI International 2870 Zanker Road, Suite 140, San Jose, CA 95134

      Register: Monte Jade Secretary Office (408)428-0388; judychu@...

      For more information, please visit www.montejade.org

      Please pay at site, Member $5, Non-Member $10

      Speech is delivered in Chinese

      Water and snacks are provided

      Dr. Kung is a founding and managing member of Vivo Ventures, LLC
      (formerly BioAsia Investments), a healthcare/biotechnology venture
      capital management firm. Vivo Ventures, currently with $400MM under
      management, is a therapeutic product company focused venture capital
      firm, formed in 1996. With over 90 years of combined medical and
      operational expertise in life sciences and therapeutic product
      companies, the Vivo team makes investment decisions for the Funds and
      helps portfolio companies developing corporate strategies, arranging
      licensing agreements and strategic alliances, recruiting key
      management, and acquiring new products and technology to accelerate
      growth. Vivo has invested in more than 70 private and public
      biotechnology companies in the areas of biopharmaceuticals, specialty
      pharmaceuticals, and medical devices.

      Dr. Kung started his career in the biotechnology industry in 1979 when
      he joined Cetus Corporation. He co-founded Cetus Immune Corporation in
      1981, which was acquired by its parent company in 1983. In 1984 he
      co-founded Genelabs Technologies, Inc. (NADSAQ: GNLB) where he served
      as Chairman and CEO until 1995. He brought the company public in 1991,
      and built it to a 175 employee international biotech company with
      operations in the United States, Belgium, Singapore, Switzerland and
      Taiwan. Dr. Kung received his B.S. in chemistry from the National
      Tsing Hua University in Taiwan, his Ph.D. in molecular biology and MBA
      from the University of California, Berkeley. He received the Best Use
      of Technology Award from the Governor of California, the Entrepreneur
      of the Year Awards from Ernst and Young, and the Asian Business
      League. He also served on the board of directors of the Biotechnology
      Industry Organization (BIO); Mt. Jade Science and Technology
      Association, West Coast; and the Asian American Manufacturing
      Association. He was appointed by the U.S. Secretary of Health and
      Human Services as a voting member of the National Biotechnology Policy
      Board. Dr. Kung currently serves on the board of directors of a number
      of emerging biotechnology companies.
    Your message has been successfully submitted and would be delivered to recipients shortly.